trending Market Intelligence /marketintelligence/en/news-insights/trending/KQCkOpOHXiIo3JFn2OH3tg2 content esgSubNav
In This List

Nephros receives US FDA marketing clearance for HydraGuard system

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Nephros receives US FDA marketing clearance for HydraGuard system

Nephros Inc. received 510(k) clearance from the U.S. FDA for its HydraGuard 10" UltraFilter, a system for use with a hemodialysis machine for the treatment of patients with end stage renal disease.

The product is designed to provide hospitals and medical facilities with a long-term solution to protect patients from bacteria that may be present in the potable water systems.